Literature DB >> 18925646

Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c.

C Nakada1, K Matsuura, Y Tsukamoto, M Tanigawa, T Yoshimoto, T Narimatsu, L T Nguyen, N Hijiya, T Uchida, F Sato, H Mimata, M Seto, M Moriyama.   

Abstract

We investigated expression profiles of microRNA (miRNA) in renal cell carcinoma [clear cell carcinomas (CCC) and chromophobe renal cell carcinomas (ChCC)] and in normal kidneys by using a miRNA microarray platform which covers a total of 470 human miRNAs (Sanger miRBase release 9.1). Unsupervised hierarchical cluster analysis revealed that CCC and ChCC were separable and that no subgroups were identified in CCCs. We found that 43 miRNAs were differentially expressed between CCC and normal kidney, of which 37 were significantly down-regulated in CCC and the other 6 were up-regulated. We also found that 57 miRNAs were differentially expressed between ChCC and normal kidney, of which 51 were significantly down-regulated in ChCC and the other 6 were up-regulated. Together, these observations indicate that expression of miRNAs tends to be down-regulated in both CCC and ChCC compared with normal kidney. We observed that miR-141 and miR-200c were the most significantly down-regulated miRNAs in CCCs. Indeed, in all cases of CCC analysed, both miR-141 and miR-200c were down-regulated in comparison with normal kidney. Microarray data and quantitative RT-PCR showed that these two miRNAs were expressed concordantly. TargetScan algorithm revealed that ZFHX1B mRNA is a hypothetical target of both miR-141 and -200c. We established by quantitative RT-PCR that, in CCCs in which miR-141 and miR-200c were down-regulated, ZFHX1B, a transcriptional repressor for CDH1/E-cadherin, tended to be up-regulated. Furthermore, we found that overexpression of miR-141 and miR-200c caused down-regulation of ZFHX1B and up-regulation of E-cadherin in two renal carcinoma cell lines, ACHN and 786-O. On the basis of these findings, we suggest that down-regulation of miR-141 and miR-200c in CCCs might be involved in suppression of CDH1/E-cadherin transcription via up-regulation of ZFHX1B.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18925646     DOI: 10.1002/path.2437

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  135 in total

Review 1.  Epigenetics of kidney cancer and bladder cancer.

Authors:  Amanda M Hoffman; Paul Cairns
Journal:  Epigenomics       Date:  2011-02       Impact factor: 4.778

2.  Cloning and identification of microRNAs in bovine alveolar macrophages.

Authors:  Guangxian Xu; Yan Zhang; Hao Jia; Juan Li; Xiaoming Liu; John F Engelhardt; Yujiong Wang
Journal:  Mol Cell Biochem       Date:  2009-06-09       Impact factor: 3.396

Review 3.  MicroRNA: a new frontier in kidney and blood pressure research.

Authors:  Mingyu Liang; Yong Liu; Domagoj Mladinov; Allen W Cowley; Hariprasad Trivedi; Yi Fang; Xialian Xu; Xiaoqiang Ding; Zhongmin Tian
Journal:  Am J Physiol Renal Physiol       Date:  2009-04-01

4.  MicroRNA expression signatures of stage, grade, and progression in clear cell RCC.

Authors:  Banumathy Gowrishankar; Ilsiya Ibragimova; Yan Zhou; Michael J Slifker; Karthik Devarajan; Tahseen Al-Saleem; Robert G Uzzo; Paul Cairns
Journal:  Cancer Biol Ther       Date:  2013-12-18       Impact factor: 4.742

Review 5.  Aberrantly expressed microRNAs in bladder cancer and renal cell carcinoma.

Authors:  Akira Kurozumi; Yusuke Goto; Atsushi Okato; Tomohiko Ichikawa; Naohiko Seki
Journal:  J Hum Genet       Date:  2016-06-30       Impact factor: 3.172

Review 6.  microRNAs in kidneys: biogenesis, regulation, and pathophysiological roles.

Authors:  Kirti Bhatt; Qing-Sheng Mi; Zheng Dong
Journal:  Am J Physiol Renal Physiol       Date:  2011-01-12

7.  miR-129-3p, as a diagnostic and prognostic biomarker for renal cell carcinoma, attenuates cell migration and invasion via downregulating multiple metastasis-related genes.

Authors:  Xuanyu Chen; Anming Ruan; Xuegang Wang; Weiwei Han; Rong Wang; Ning Lou; Hailong Ruan; Bin Qiu; Hongmei Yang; Xiaoping Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2014-05-07       Impact factor: 4.553

8.  Development and validation of a microRNA-based diagnostic assay for classification of renal cell carcinomas.

Authors:  Yael Spector; Eddie Fridman; Shai Rosenwald; Sofia Zilber; Yajue Huang; Iris Barshack; Orit Zion; Heather Mitchell; Mats Sanden; Eti Meiri
Journal:  Mol Oncol       Date:  2013-03-26       Impact factor: 6.603

Review 9.  [MicroRNA in uro-oncology : New hope for the diagnosis and treatment of tumors?].

Authors:  A Schaefer; M Jung; G Kristiansen; M Lein; M Schrader; K Miller; A Erbersdobler; C Stephan; K Jung
Journal:  Urologe A       Date:  2009-08       Impact factor: 0.639

10.  MicroRNA-141 regulates Smad interacting protein 1 (SIP1) and inhibits migration and invasion of colorectal cancer cells.

Authors:  Minghua Hu; MicroGene Xia; Xiaobing Chen; Zihong Lin; Yajun Xu; Yuedong Ma; Lei Su
Journal:  Dig Dis Sci       Date:  2009-10-15       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.